Intuitive Surgical (NASDAQ:ISRG) Upgraded by TD Cowen to Strong-Buy Rating

Intuitive Surgical (NASDAQ:ISRG) was upgraded by TD Cowen to a “strong-buy” rating in a research note issued to investors on Tuesday,Zacks.com reports.

Other equities analysts have also recently issued research reports about the company. Wells Fargo & Company raised their price objective on Intuitive Surgical from $600.00 to $654.00 and gave the company an “overweight” rating in a report on Friday, December 12th. Barclays set a $712.00 price objective on Intuitive Surgical and gave the stock an “overweight” rating in a research note on Monday. HSBC boosted their target price on shares of Intuitive Surgical from $644.00 to $653.00 and gave the stock a “buy” rating in a report on Monday. UBS Group reiterated a “neutral” rating on shares of Intuitive Surgical in a research note on Thursday, January 15th. Finally, Argus upped their target price on shares of Intuitive Surgical from $600.00 to $630.00 in a report on Monday, October 27th. Two research analysts have rated the stock with a Strong Buy rating, fourteen have assigned a Buy rating, eight have assigned a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $620.41.

Intuitive Surgical Stock Down 0.7%

NASDAQ:ISRG opened at $525.04 on Tuesday. The company has a market cap of $188.21 billion, a P/E ratio of 66.55, a price-to-earnings-growth ratio of 4.12 and a beta of 1.67. Intuitive Surgical has a twelve month low of $425.00 and a twelve month high of $609.08. The business has a 50 day moving average price of $561.53 and a two-hundred day moving average price of $511.67.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings data on Thursday, January 22nd. The medical equipment provider reported $2.53 EPS for the quarter, topping analysts’ consensus estimates of $2.27 by $0.26. The business had revenue of $2.87 billion for the quarter, compared to analyst estimates of $2.72 billion. Intuitive Surgical had a net margin of 28.38% and a return on equity of 15.06%. The firm’s revenue for the quarter was up 18.8% on a year-over-year basis. During the same quarter in the previous year, the firm posted $2.21 earnings per share. As a group, analysts anticipate that Intuitive Surgical will post 6.43 earnings per share for the current fiscal year.

Insider Buying and Selling

In other Intuitive Surgical news, SVP Mark Brosius sold 464 shares of the business’s stock in a transaction dated Monday, December 15th. The shares were sold at an average price of $548.49, for a total value of $254,499.36. Following the completion of the sale, the senior vice president owned 131 shares of the company’s stock, valued at $71,852.19. The trade was a 77.98% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, insider Gary S. Guthart sold 22,806 shares of the firm’s stock in a transaction that occurred on Monday, December 1st. The stock was sold at an average price of $570.89, for a total transaction of $13,019,717.34. Following the transaction, the insider directly owned 2,694 shares in the company, valued at $1,537,977.66. This represents a 89.44% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold a total of 48,027 shares of company stock valued at $27,402,696 in the last 90 days. 0.70% of the stock is currently owned by corporate insiders.

Hedge Funds Weigh In On Intuitive Surgical

Hedge funds have recently added to or reduced their stakes in the stock. Brighton Jones LLC lifted its position in Intuitive Surgical by 24.9% during the fourth quarter. Brighton Jones LLC now owns 3,672 shares of the medical equipment provider’s stock worth $1,916,000 after purchasing an additional 731 shares during the period. Sivia Capital Partners LLC raised its position in shares of Intuitive Surgical by 3.8% in the 2nd quarter. Sivia Capital Partners LLC now owns 928 shares of the medical equipment provider’s stock valued at $504,000 after buying an additional 34 shares in the last quarter. Raleigh Capital Management Inc. lifted its holdings in shares of Intuitive Surgical by 23.8% during the 2nd quarter. Raleigh Capital Management Inc. now owns 307 shares of the medical equipment provider’s stock worth $167,000 after acquiring an additional 59 shares during the period. Truist Financial Corp increased its stake in Intuitive Surgical by 1.7% in the second quarter. Truist Financial Corp now owns 260,572 shares of the medical equipment provider’s stock valued at $141,597,000 after acquiring an additional 4,280 shares during the last quarter. Finally, PGGM Investments raised its position in Intuitive Surgical by 972.9% during the second quarter. PGGM Investments now owns 51,425 shares of the medical equipment provider’s stock valued at $27,945,000 after purchasing an additional 46,632 shares in the last quarter. Institutional investors own 83.64% of the company’s stock.

Trending Headlines about Intuitive Surgical

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: TD Cowen initiated coverage with a Buy and a $660 target, citing the da Vinci 5 rollout and secular procedure growth as catalysts that could drive multi-year revenue and margin upside. TD Cowen initiates coverage
• Positive Sentiment: TD Cowen / TipRanks coverage note expands on the same thesis, highlighting da Vinci 5 rollout execution and secular procedure growth as underpinning a $660 target. TipRanks: TD Cowen Buy Rating
• Positive Sentiment: The FDA granted 510(k) clearance for the da Vinci 5 in select cardiac procedures, expanding the platform into more minimally invasive heart surgeries — a direct product/regulatory win that can support procedure growth and long-term consumable revenue. da Vinci 5 FDA clearance
• Positive Sentiment: HSBC raised its price target to $653 and maintained a Buy, reinforcing bullish analyst sentiment and implying meaningful upside from current levels. HSBC raises PT to $653
• Positive Sentiment: Barclays reiterated its Buy rating, another vote of confidence from the sell-side that supports investor sentiment. Barclays remains Buy
• Positive Sentiment: American Banking News reports a raised price target to $615, adding to the cluster of higher analyst targets that can support upside expectations. Price target raised to $615
• Neutral Sentiment: Interest in ISRG is high among retail/institutional investors (searches up), which can increase short-term volatility but does not by itself change fundamentals. Investors heavily search ISRG
• Negative Sentiment: Zacks highlights rising competitive pressure in China — slower tenders, local favoritism and pricing pressure — which could weigh on growth and margins in a key market if trends accelerate. China competition headwinds
• Negative Sentiment: Robert W. Baird trimmed its price target to $645 — a modest downgrade that could temper upside expectations even though the target remains above current levels. Baird cuts PT to $645

Intuitive Surgical Company Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.